During this session, representatives of global regulatory bodies, industry, and academia who are directly involved in the management of the regulatory process exchanged knowledge and experiences on the evolving regulatory environment of medical products regarding initiatives of convergence, both regional and international agencies, and understand how it helps streamline the regulatory process to facilitate the achievement of public health goals.
COVID-19 pandemic has highlighted the importance of strategies to strengthen the regulatory systems in Latin America, intended to warrant safety, quality and efficacy of medicines and other self-care products. This event will gather recognized experts in the region to share on their reflections on those strategies.
Panel Invitees:
Webinar materials are available by clicking the following links:
Thematic session on Good Regulatory Practices examining the impact on the sectors of medical devices and new vehicle technologies. The medical device session included presentations from the FDA, Health Canada, the Coalition, the EU and Japan. Session, Slides Deck, Talking Points and Video Webcast. The table below shows the time at the recording where you can listen to specific presentations:
| FDA | 0:08:00-0:16:00 |
| Health Canada | 0:16:00-0:31:00 |
| Inter-American Coaliton for Regulatory Convergence | 0:31:00-0:48:30 |
| EU | 0:48:00-1:10:00 |
| Japan | 1:10:00-1:13:00 |
REGULATORY COALITION PRINCIPAL MEMBERS
